At SCYNEXIS, we are bringing a ground-breaking class of drugs to the battle by developing innovative products that have the strength, safety, and versatility to defeat even the most insidious fungal diseases. We are committed to positively impacting the lives of patients suffering from fungal infections — from the most common to the difficult-to-treat and deadliest. (NASDAQ: SCYX) The SCYNEXIS team has deep expertise in anti-infective drug development and marketing, which can be leveraged to advance ibrexafungerp from clinical development to commercialization.
View Top Employees from SCYNEXIS, Inc.Website | http://www.scynexis.com |
Ticker | SCYX |
Revenue | $11 million |
Funding | $252 million |
Employees | 85 (85 on RocketReach) |
Founded | 2000 |
Address | 1 Evertrust Plaza, Jersey City, New Jersey 07302, US |
Phone | (201) 884-5485 |
Fax | (201) 884-5490 |
Technologies |
JavaScript,
HTML,
Twitter
+26 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Health Care, Antifungals, Pharmaceuticals, Manufacturing, Drug Development, Healthcare, Pharmaceutical |
Web Rank | 4 Million |
Keywords | Scynexis, Sycnexis, Ibrexafungerp, Scy078 Antifungal, Biotechnology Companies In New Jersey |
Competitors | Cidara Therapeutics, CreaGen, Inc., Praecis Pharmaceuticals, Provid Pharmaceuticals, Selvita S.A |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular SCYNEXIS, Inc. employee's phone or email?
The SCYNEXIS, Inc. annual revenue was $11 million in 2024.
Ivor Macleod is the CFO of SCYNEXIS, Inc..
85 people are employed at SCYNEXIS, Inc..
SCYNEXIS, Inc. is based in Jersey City, New Jersey.
The NAICS codes for SCYNEXIS, Inc. are [3254, 32541, 325, 32, 541, 54].
The SIC codes for SCYNEXIS, Inc. are [28, 283].